Mainstream

Zevra Therapeutics signals accelerated MIPLYFFA adoption and $148.3M capital infusion while expanding global reach

Zevra Therapeutics signals accelerated MIPLYFFA adoption and $148.3M capital infusion while expanding global reach

Post ContentzvraRead More

You might also be interested in reading Gary Gensler is leaving the SEC, but replacement will face scrutiny.

May 14, 2025
In Mainstream